Marshall Wace North America’s Celldex Therapeutics CLDX Stock Holding History

Marshall Wace North America’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell
2021 Q1	$500K	Sell
2020 Q4	$22.5M	Buy
2020 Q3	$3.78M	Buy